• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

MIAS&M's Profile

Avatar:

Membership:

Premium

Person Marks:

1

Total Posts:

93

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

0

Alias Born

02/12/2016 4:00:12 PM

Personal info

Recent Articles

• Maximize Your Tesla's Efficiency and Performance This Winter
• Cardone Ventures and 10X Health Ventures Legal Action Explained
• Capri Holdings Limited Faces Legal Scrutiny: What You Need to Know
• Legal Action Initiated Against Nextracker Inc. for Investor Claims
• Cathie Wood's ARK Fund Expands With AMD and TEMPUS AI Investments
• Mustang Energy Corp. Secures $3.55 Million in Latest Financing
• Important Legal Insights for Transocean Ltd. Shareholders
• The Incredible Growth of Booz Allen Hamilton Over a Decade
• US Treasury May Face Critical Debt Limit Challenge Ahead
• Q-Gold Resources Completes Successful Financing Round for Growth
• Discovering the Growth of $1000 in Verisk Analytics Investment
• Big Lots Announces Strategic Asset Transfer to Retail Partners
• Trump Seeks Supreme Court Intervention on TikTok Law
• Lifeward's Upcoming Shareholder Meeting Set for January 2025
• Fobi AI's Strategic Move: Proposed Placement and BCSC Response
• Investigation Launched: MediaAlpha Inc. Faces Serious Allegations
• Opdivo Qvantig™ Approved: A Game-Changer in Cancer Care
• Investigation Launched into e.l.f. Beauty, Inc. Allegations
• Investigation Into Oklo Inc. Sparks Concerns for Investors
• Univest Securities Secures Successful $2.8 Million Offering
• Exploring Innovations in Toxicology at Upcoming ACMT Meeting
• Clear Blue Technologies Unveils Strategic Financial Restructuring
• Abaxx Technologies Strengthens Position in MineHub Shares
• Genius Group Reports Significant Growth in Assets for 2024
• VR Resources Completes Private Placement to Fuel Exploration Work
• Investigation Alerts for Spyre Therapeutics Investors Amid Concerns
• Investigation Launched for Arvinas, Inc. Investors Amid Concerns
• Investigation of Codere Online Luxembourg, S.A. Investors' Claims
• Blue Origin's New Glenn Rocket Launch License Approved
• Workers in Brazil Secure Support Amid BYD's Controversy
• Russia's Alleged Role in Azerbaijan Airlines Crash Raises Concerns
• Understanding Your Rights if You Lost in IMX Tokens
• Exploring the Profitability of Fluor Stock Over Five Years
• Advocating for Equity and Diversity in Neuroscientific Studies
• Ascend Wellness Holdings Reveals New Share Buyback Initiative
• University of Phoenix Launches Pathways for Workforce Growth
• Citius Pharmaceuticals' Growth Outlook Amid Strong 2024 Results
• Investigation Launched for Shareholders of Sana Biotechnology
• Citius Oncology's 2024 Financial Overview: Major Developments
• Investigation of Celanese Corporation: A Closer Look at CE
• Investigation into Airship AI Holdings, Inc. Claims by Law Firm
• Data Security Incident Notice by The Baker Center for Families
• Citius Oncology's Annual Performance: A Year of Strategic Growth
• Citius Pharmaceuticals Reflects on 2024 Financial Performance
• Willow Lane Acquisition Corp. Enables Independent Trading of Units
• Investigation of Innovative Industrial Properties: What Investors Should Know
• Ascend Wellness Holdings Initiates Strategic Share Buyback Program
• Investigation of Neurogene Inc. Raises Concerns for Investors
• OpenAI Transitions to Public Benefit Corporation for Growth
• Vanguard and US Bank Regulator Agree on Control Measures